Liesbeth H. De Waele

Gent, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 93 publications

TKI-associated proteinuria and nephrotic syndrome: a narrative review with clinical illustration in radio-iodine-refractory thyroid cancer.

TKI-associated proteinuria and nephrotic syndrome: a narrative review with clinical illustration in radio-iodine-refractory thyroid cancer.

Journal: Acta clinica Belgica

Published: June 07, 2026

Corrigendum to "The unmet need of psychopharmacological intervention for neuropsychiatric and neurodevelopmental comorbidities in Duchenne muscular dystrophy: report of 5 workshops" [Eur. J. Paediatr. Neurol. (2026) 61 84-89].

Corrigendum to "The unmet need of psychopharmacological intervention for neuropsychiatric and neurodevelopmental comorbidities in Duchenne muscular dystrophy: report of 5 workshops" [Eur. J. Paediatr. Neurol. (2026) 61 84-89].

Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society

Published: June 06, 2026

Change in respiratory outcomes in adults with Duchenne muscular dystrophy in the era of corticosteroids.

Change in respiratory outcomes in adults with Duchenne muscular dystrophy in the era of corticosteroids.

Journal: Journal of neuromuscular diseases

Published: May 13, 2026

Clinical characteristics, neurosurgical management, and outcomes of pediatric abusive head trauma: a 30-year single-center study.

Clinical characteristics, neurosurgical management, and outcomes of pediatric abusive head trauma: a 30-year single-center study.

Journal: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery

Published: May 09, 2026

Balancing Benefits and Risks: Long-term Use of Daily versus Intermittent Corticosteroids in Duchenne Muscular Dystrophy.

Balancing Benefits and Risks: Long-term Use of Daily versus Intermittent Corticosteroids in Duchenne Muscular Dystrophy.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: April 02, 2026

Burden of illness of Duchenne muscular dystrophy in Belgium: A retrospective, descriptive, cross-sectional study.

Burden of illness of Duchenne muscular dystrophy in Belgium: A retrospective, descriptive, cross-sectional study.

Journal: Journal of neuromuscular diseases

Published: March 14, 2026

Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial.

Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial.

Journal: Nature medicine

Published: January 28, 2026

Closing the Gap to Interventions for Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND): Protocol for a Longitudinal Study of TAND Severity, Predictors, and Caregiver Well-Being (TANDem-2).

Closing the Gap to Interventions for Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND): Protocol for a Longitudinal Study of TAND Severity, Predictors, and Caregiver Well-Being (TANDem-2).

Journal: JMIR research protocols

Published: January 22, 2026

The unmet need of psychopharmacological intervention for neuropsychiatric and neurodevelopmental comorbidities in Duchenne muscular dystrophy: report of 5 workshops.

The unmet need of psychopharmacological intervention for neuropsychiatric and neurodevelopmental comorbidities in Duchenne muscular dystrophy: report of 5 workshops.

Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society

Published: November 21, 2025

A plain language summary of the SAPPHIRE clinical trial of apitegromab in children and young adults with spinal muscular atrophy.

A plain language summary of the SAPPHIRE clinical trial of apitegromab in children and young adults with spinal muscular atrophy.

Journal: Expert review of neurotherapeutics

Published: November 13, 2025

Reviewer Comment on Gauvreau et al. "Respiratory and Bulbar Support in Spinal Muscular Atrophy Type I Treated with Nusinersen".

Reviewer Comment on Gauvreau et al. "Respiratory and Bulbar Support in Spinal Muscular Atrophy Type I Treated with Nusinersen".

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: October 03, 2025

Parental illness intrusiveness in parents of children with neuromuscular disorders.

Parental illness intrusiveness in parents of children with neuromuscular disorders.

Journal: Journal of neuromuscular diseases

Published: September 18, 2025

Showing 1-12 of 93

Last Updated: 09/26/2026